Alteration of cell wall composition leads to amphotericin B resistance in Aspergillus flavus

Microbiology and Immunology

Volumn 43, Issue 11, 1999, Pages 1017-1025

  Seo, Kuniko ^a,b   Akiyoshi, Hiroto ^a   Ohnishi, Yoshinari ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Amphotericin B; Aspergillus flavus; Cell wall; Resistance

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; CELL MEMBRANE PROTEIN; CICLOPIROXOLAMINE; CLOTRIMAZOLE; DODECYL SULFATE SODIUM; FLUCYTOSINE; GLUCAN; NYSTATIN; TRICHOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; ASPERGILLUS FLAVUS; BACTERIAL CELL WALL; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; MYCELIUM; NONHUMAN; PROTEIN CONTENT; SPHEROPLAST;

ASPERGILLUS FLAVUS;

EID: 0032757026     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1999.tb01231.x     Document Type: Article

References (49)

1. Athar, M.A., and Winner, H.L. 1971. The development of resistance by Candida albicans to polyene antibiotics in vitro. J. Med. Microbiol. 4: 505-517.
2. Barnes, A.J., and Denning, D.W. 1993. Aspergilli - significance as pathogens. Rev. Med. Microbiol. 4: 176-180.
3. Beezer, A.E., Miles, R.J., Park, W.B., Smith, A.R.W., and Brain, A.P.R. 1986. A nystatin-resistant mutant of Saccharomyces cerevisiae: isolation and characterization by electron microscopy and chemical analysis of whole cells, cell-walls and protoplasts. Microbios 47: 117-126.
4. Beezer, A.E., Miles, R.J., Park, W.B., and Smith, A.R.W. 1986. Uptake of nystatin by protoplasts of sensitive and resistant cells of Saccharomyces cerevisiae. Microbios 48: 7-16.
5. Bligh, E.G., and Dyer, W.J. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
6. Bodey, G., Bueltmann, B., Duguid, W., Gibbs, D., Hanak, H., Hotchi, M., Mall, G., Martino, P., Meunier, F., Milliken, S., Naoe, S., Okudaira, M., Scevola, D., and van't Wout, J. 1992. Fungal infections in cancer patients: an international autopsy survey. Europ. J. Clin. Microb. Infect. Dis. 11: 99-109.
7. Brajtburg, J., Powderly, W.G., Kobayashi, G.S., and Medoff, G. 1990. Amphotericin B: current understanding of mechanisms of action. Antimicrob. Agents Chemother. 34: 183-188.
8. Brajtburg, J., Powderly, W.G., Kobayashi, G.S., and Medoff, G. 1990. Amphotericin B: delivery systems. Antimicrob. Agents Chemother. 34: 381-384.
9. Cassone, A., Kerridge, D., and Gale, E.F. 1979. Ultrastructural changes in the cell wall of Candida albicans following cessation of growth and their possible relationship to the development of polyene resistance. J. Gen. Microbiol. 110: 339-349.
10. Cohen, B.E. 1998. Amphotericin B toxicity and lethality: a tale of two channels. Int. J. Pharmaceut. 162: 95-106.
11. Danilenko, I.I., and Stepanyuk, V.V. 1982. Ultrastructure, composition of neutral lipids and their fatty acids of Candida tropicalis strain D-2 mutants resistant to the polyene antibiotic nystatin. Biochim. Biophys. Acta 691: 201-210.
12. Denning, D.W., Follansbee, S., Scolaro, M., Norris, S., Edelstein, D., and Stevens, D.A. 1991. Pulmonary aspergillosis in AIDS. N. Engl. J. Med. 324: 654-662.
13. Dismukes, W.E., Cloud, G., Gallis, H., Kerkering, T.M., Medoff, G., Craven, P.C., Kaplowitz, L.G., Fisher, J.F., Gregg, C.R., Bowles, C.A., Shadomy, S., Stamm, A.M., Diasio, R.B., Kaufman, L., Soong, S.J., Blackwelder, W.C., and the NIAID Mycosis Study Group. 1987. Treatment of cryptococcal meningitis with combination of amphotericin B and flucytosine for four as compared with six weeks. N. Engl. J. Med. 317: 334-341.
14. Dubois, M., Gilles, K.A., Hamilton, J.K., and Smith, F. 1956. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28: 350-356.
15. Fukui, K., Sagara, Y., Yoshida, N., and Matsuoka, T. 1969. Analytical studies on regeneration of protoplasts of Geotrichum candidum by quantitative thin-layer-agar plating. J. Bacteriol. 98: 256-263.
16. Gale, E.F. 1974. The release of potassium ions from Candida albicans in the presence of polyene antibiotics. J. Gen. Microbiol. 80: 451-465.
17. Gale, E.F., Johnson, A.M., Kerridge, D., and Koh, T.Y. 1975. Factors affecting the changes in amphotericin sensitivity of Candida albicans during growth. J. Gen. Microbiol. 87: 20-36.
18. Gale, E.F., Ingram, J., Kerridge, D., Notario, V., and Wayman, F.J. 1980. Reduction of amphotericin resistance in stationary phase cultures of Candida albicans by treatment with enzymes. J. Gen. Microbiol. 117: 383-391.
19. Gomes, M.H.R., and Resende, M.A. 1992. Fonsecaea pedrosoi: lipid composition and determination of susceptibility to amphotericin B. Can. J. Microbiol. 38: 209-214.
20. Grunwald-Raij, H., and Margalith, P. 1990. Ethanol fermentation by nystatin-resistant strains of Saccharomyces cerevisiae. J. Appl. Bacteriol. 68: 247-252.
21. Hammond, S.M., and Kliger, B.N. 1976. Mode of action of the polyene antibiotic Candicidin: binding factors in the wall of Candida albicans. Antimicrob. Agents Chemother. 9: 561-568.
22. James, C.S., Burden, R.S., Loeffler, R.S.T., and Hargreaves, J.A. 1992. Isolation and characterization of polyene-resistant mutants from the maize smut pathogen, Ustilago maydis, defective in ergosterol biosynthesis. J. Gen. Microbiol. 138: 1437-1443.
23. Jirku, V., Cejkova, A., and Paca, J. 1981. Effect of growth factor deficiency on nystatin sensitivity in Saccharomyces cerevisiae. Experientia 37: 39-40.
24. Lampen, J. 1969. Amphotericin B and other polyenic antifungal antibiotics. Am. J. Clin. Pathol. 49: 138-146.
25. Levvy, G.A., and McAllan, A. 1959. The N-acelylation and estimation of hexosamines. Biochem. J. 73: 127-132.
26. Lorenz, R.T., Casey, W.M., and Parks, L.W. 1989. Structural discrimination in the sparking function of sterols in the yeast Saccharomyces cerevisiae. J. Bacteriol. 171: 6169-6173.
27. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275.
28. Manavathu, E.K., Alangaden, G.J., and Chandrasekar, P.H. 1998. In-vitro isolation and antifungal susceptibility of amphotericin B-resistant mutants of Aspergillus fumigatus. J. Antimicrob. Chemother. 41: 615-619.
29. Mazumder, C., Basu, J., Manikuntala, K., and Chakrabarti, P. 1990. Changes in membrane lipids and amino acid transport in a nystatin-resistant Aspergillus niger. Can. J. Microbiol. 36: 435-437.
30. Moore, C.B., Law, D., and Denning, D.W. 1993. In vitro activity of D0870 compared with amphotericin B and itraconazole against Aspergillus spp. J. Antimicrob. Chemother. 32: 831-836.
31. Morrison, V.A., Haake, R.J., and Weisdorf, D.J. 1994. Non-candida fungal infections after bone marrow transplantation: risk factors and outcome. Am. J. Med. 96: 497-503.
32. Nobre, G.M., Pereira, A., Coias, R., and Cordeiro, J. 1980. In vitro development of resistance to nystatin by Candida albicans and Torulopsis glabrata. J. Gen. Microbiol. 118: 263-265.
33. Parks, L.W., Bottema, C.D.K., Rodriguez, R.J., and Lewis, T.A. 1985. Yeast sterols: yeast mutants as tools for the study of sterol metabolism. Methods Enzymol. 111: 333-346.
34. Parks, L.W., Rodriguez, R.J., and Low, C. 1986. An essential fungal growth factor derived from ergosterol: a new end product of sterol biosynthesis? Lipids 21: 89-91.
35. Patel, R., and Paya, C.V. 1997. Infections in solid-organ transplant recipients. Clin. Microbiol. Rev. 10: 86-124.
36. Pierce, A.M., Pierce, H.D., Unrau, A.M., and Oehlschlager, A.C. 1978. Lipid composition and polyene antibiotic resistance of Candida albicans mutants. Can. J. Biochem. 56: 135-142.
37. Pursell, K.J., Telzak, E.E., and Armstrong, D. 1992. Aspergillus species colonization and invasive disease in patients with AIDS. Clin. Infect. Dis. 14: 141-148.
38. Ramanandraibe, E., Younsi, M., Coulon, J., Loppinet, V., Hakkou, A., and Bonaly, R. 1998. Implication of cell wall constituents in the sensitivity of Kluyveromyces lactis strains to amphotericin B. Res. Microbiol. 149: 109-118.
39. Resende, M.A., and Alterthum, F. 1990. Effect of nystatin, amphotericin B and methyl ester on Saccharomyces cerevisiae with different lipid composition. Mycopathologia 112: 165-172.
40. Richman-Boytas, C.M., and Parks, L.W. 1989. Effect of sterol alterations on nystatin sensitivity in Saccharomyces cerevisiae. Microbios 59: 101-111.
41. Rinaldi, M.G. 1993. Invasive aspergillosis. Rev. Infect. Dis. 5: 1061-1073.
42. Russell, N.J., Kerridge, D., and Gale, E.F. 1975. Polyene sensitivity during germination of conidia of Aspergillus fumigatus. J. Gen. Microbiol. 87: 351-358.
43. Saag, M.S., and Dismukes, W.E. 1988. Azole antifungal agents: emphasis on new triazoles. Antimicrob. Agents Chemother. 32: 1-8.
44. Sokol-Anderson, M., Brajtburg, J., and Medoff, G. 1986. Amphotericin B-induced oxidative damage and killing of Candida albicans. J. Infect. Dis. 154: 76-83.
45. Sud, I.J., and Feingold, D.S. 1983. Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans. Antimicrob. Agents Chemother. 23: 185-187.
46. Virina, A.M., Belousova, I.I., and Tereshin, I.M. 1981. Composition and characteristics of Candida albicans cells differing in resistance to polyene antibiotics. Curr. Microbiol. 5: 139-142.
47. Wolf, B.D., and Hartsel, S.C. 1995. Osmotic stress sensitizes sterol-free phospholipid bilayers to the action of amphotericin B. Biochim. Biophys. Acta 1238: 156-162.
48. Woods, R.A. 1971. Nystatin-resistant mutants of yeast: alterations in sterol content. J. Bacteriol. 108: 69-73.
49. Zonneveld, B.J.M. 1972. Morphogenesis in Aspergillus nidulans: the significance of α-1,3-glucan of the cell wall and α-1,3-glucanase for cleistothecium development. Biochim. Biophys. Acta 273: 174-187.